Job Growth During the Recovery, and More from CRS
New and updated reports from the Congressional Research Service that Congress has not made available to the public include the following.
Job Growth During the Recovery, updated October 16, 2012
The President’s Emergency Plan for AIDS Relief (PEPFAR): Funding Issues After a Decade of Implementation, FY2004-FY2013, October 10, 2012
Statutes of Limitation in Federal Criminal Cases: An Overview, updated October 1, 2012
Venezuela: Issues for Congress, updated October 16, 2012
Georgia’s October 2012 Legislative Election: Outcome and Implications, October 15, 2012
Iran Sanctions, updated October 15, 2012
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.